The percentage of patients with pediatric melanoma is 6-fold to the 28-fold higher when compared with the general population of patients with melanoma.
A study shows stress may affect certain cellular, cytokine, and chemokine markers in the body of patients with CLL.
A study in Cancer found a lower risk of prostate cancer–specific death and improved overall survival when patients were treated with this combination.
A study shows treatment with ibrutinib is superior to chemoimmunotherapy for patients with chronic treatment-naive CLL.
A study shows T1a RCC patients have improved overall survival when receiving partial nephrectomy compared with radical nephrectomy.
The Short-HER study was unable to show noninferiority of 9 weeks of trastuzumab compared with the standard 1 year in women with HER2-positive breast cancer.
A radiographic measure may help clinicians distinguish between benign renal oncocytoma and chromophobe renal cell carcinoma.
Nearly 10 years of follow-up from a large clinical trial have confirmed that axillary dissection is not necessary in patients with early breast cancer.
A study shows that combined hormonal contraceptive use is associated with a significant reduction in the risk of ovarian cancer.
Patients with von Hippel-Lindau disease may have a new treatment option in the antiangiogenic therapy pazopanib.